Entasis Therapeutics Holdings Inc (ETTX) stock is down -61.52% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ETTX stock a score of 32 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 3. ETTX's rank also includes a long-term technical score of 4. The fundamental score for ETTX is 90. In addition to the average rating from Wall Street analysts, ETTX stock has a mean target price of 6.25. This means analysts expect the stock to gain 209.41% over the next 12 months.
What's Happening with ETTX Stock Today
Entasis Therapeutics Holdings Inc (ETTX) stock is higher by 1% while the S&P 500 has gained 0.18% as of 2:16 PM on Monday, Dec 14. ETTX has gained $0.02 from the previous closing price of $2.00 on volume of 779,482 shares. Over the past year the S&P 500 is higher by 14.99% while ETTX is down -61.52%. ETTX lost -$3.36 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Entasis Therapeutics Holdings Inc (ETTX) Stock.
